Screener
Pulse Biosciences, Inc. PLSE Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | -0.1%— | -21.6%— | -55.1%— | -224.4%— | —— | |
| Operating margin | -7,007.8%— | -10,392.1%— | -21,982.6%— | -91,798.8%— | —— | |
| Net margin | -6,755.8%— | -9,929%— | -20,794.6%— | -86,898.8%— | —— | |
| Returns | ||||||
| Return on equity | -78.5%+25.0pp | -80.7%-2.9pp | -74.4%-7.1pp | -87%-16.7pp | -103.5%-2.8pp | |
| Return on invested capital | -1,505.1%-591pp | -1,211.5%-506pp | -1,168.1%-411pp | -1,141.3%-646pp | -914.4%-471pp | |
| Efficiency | ||||||
| Asset turnover | 0×— | 0×— | 0×— | 0×— | 0×— | |
| Liquidity | ||||||
| Current ratio | 9.6×-2.4× | 7.3×-8.3× | 10.5×-1.4× | 10×-1.9× | 12×+7.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.2× | |
| Valuation | ||||||
| Market capitalization | $3.55B+178% | $1.47B+38.4% | $930.45M-13.1% | $1.19B+18.8% | $1.04B+67.8% | |
| Price / sales | 2,999.2×-11,861× | 1,954.6×— | 2,658.4×— | 13,850.4×— | —— | |
| Price / book | 35.7×+21.9× | 22.1×+13.2× | 11.5×+2.2× | 12.9×+0.2× | 9.9×-13.0× |
FAQ
- What are Pulse Biosciences, Inc.'s profit margins?
- Pulse Biosciences, Inc. (PLSE) runs a -0.1% gross margin and a -7007.8% operating margin, with a -6755.8% net margin.
- Where do Pulse Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Pulse Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
